Klarity Health

About Klarity Health

Klarity Health launched in 2020 as a telehealth platform primarily focused on ADHD and mental health services, and has since expanded into GLP-1 weight management. The platform offers compounded semaglutide through its Klarity Select program, with costs structured as a initial visit fee plus 9/month for medication. This pricing model is transparent and predictable, though the combined cost of approximately 8 for the first month places Klarity in the mid-range tier.

On Trustpilot, Klarity holds a 4.0 rating across 490+ reviews, a solid score that reflects generally positive patient sentiment. The company carries an A rating with the BBB, indicating strong business practices and effective complaint resolution. These trust metrics are encouraging, particularly for a company that has expanded into a new clinical domain. The A BBB rating provides a level of institutional credibility that many GLP-1-focused competitors lack.

The clinical support model is medium-tier. Klarity provides provider consultations and prescription management, but does not include the dedicated nutrition coaching, dietitian access, or comprehensive lab testing that high-support competitors offer as standard. The Klarity Select program is the company’s dedicated weight management track, designed to streamline the GLP-1 prescribing process and provide structured follow-up. Patients receive regular check-ins, but the depth of metabolic monitoring falls short of what specialists like Defy Medical or Hone Health provide.

One of Klarity’s distinguishing features is its dual insurance and cash-pay model. Patients can use insurance for consultations where applicable, potentially reducing costs for the visit component of treatment. The platform’s experience with insurance billing for ADHD and mental health gives it operational fluency with payer systems that pure cash-pay telehealth startups do not have. For patients whose insurance covers telehealth consultations, this can reduce the effective monthly cost meaningfully.

Klarity’s GLP-1 program is still maturing. The platform’s core competency remains mental health, and its weight management offering does not yet match the depth or medication variety of dedicated GLP-1 providers. Offering only compounded semaglutide limits patient options, and the medium-support model may not be sufficient for patients with complex metabolic needs. However, for patients who are already using Klarity for ADHD or mental health care, adding GLP-1 treatment through a familiar platform with a strong BBB rating has clear convenience advantages.

Klarity Health GLP-1 Medications

At a Glance